Circulating human cytomegalovirus-encoded HCMV-miR-US4-1 as an indicator for predicting the efficacy of IFNα treatment in chronic hepatitis B patients

The efficacy of interferon α (IFNα) therapy for chronic hepatitis B (CHB) patients is about 40% and often associates with adverse side-effects, thus identification of an easy accessible biomarker that can predict the outcome of IFNα treatment for individual CHB patients would be greatly helpful. Rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yi, Wang, Nan, Zhou, Zhenxian, Liang, Hongwei, Pan, Chaoyun, Zhu, Dihan, Liu, Fenyong, Zhang, Chen-Yu, Zhang, Yujing, Zen, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785337/
https://www.ncbi.nlm.nih.gov/pubmed/26961899
http://dx.doi.org/10.1038/srep23007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785337/
https://www.ncbi.nlm.nih.gov/pubmed/26961899
http://dx.doi.org/10.1038/srep23007

Ejemplares similares